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Abstract
Background: Estrogen receptor–positive breast cancer is the most common type of breast cancer in postmenopausal women.
Aromatase inhibitors (AIs) are the endocrine therapy of choice recommended for these patients. Up to 50% of those treated with
an AI develop arthralgia, often resulting in poor adherence and decreased quality of life.
Objective: The study is a single-arm longitudinal pilot study aiming to evaluate the safety, feasibility, acceptability, and potential
efficacy of TaiChi4Joint, a remotely delivered 12-week tai chi intervention designed to relieve AI-induced joint pain.
Methods: Women diagnosed with stage 0-III breast cancer who received an AI for at least 2 months and reported arthralgia
with a ≥4 score on a 0 to 10 scale for joint pain were eligible for study enrollment. Participants were encouraged to join tai chi
classes delivered over Zoom three times a week for 12 weeks. Program engagement strategies included using a private Facebook
study group and a Box cloud for archiving live class recordings. The program uses SMS text messaging and emails with periodic
positive quotes and evidence-based information on tai chi for facilitating community bonding and class attendance. Participants
were invited to complete the following assessments at baseline and at 1-, 2-, and 3-month intervals from study enrollment: Brief
Pain Inventory, Western Ontario and McMaster University Osteoarthritis Index (WOMAC), The Australian Canadian Osteoarthritis
Hand Index (AUSCAN), Fatigue Symptom Inventory, Hot Flash Related Daily Interference Scale (HFRDIS), Pittsburgh Sleep
Quality Index (PSQI), and Center for Epidemiological Studies–Depression (CES-D).
Results: A total of 55 eligible patients were invited to participate, and 39 (71%) consented and completed the baseline assessments.
Participants attended 61% (median) of the suggested classes, with no tai chi–related adverse events reported. Of the 39 participants,
22 completed the 3-month follow-up assessment with a 56% retention rate. Study participants reported improvement from baseline
compared to 3 months as follows (paired t test): Brief Pain Inventory (P<.001), AUSCAN pain subscale (P=.007), AUSCAN
function subscale (P=.004), Fatigue Symptom Inventory (P=.004) and PSQI (P<.001), and HFRDIS (P=.02) and CES-D (P<.001).
In particular, for our primary end point of interest, improvements in hip and knee symptoms, measured by WOMAC’s three
subscales, were clinically meaningful and statistically significant when adjusted for multiple comparisons from baseline to 3
months post intervention.
Conclusions: The COVID-19 global pandemic has resulted in the need to rethink how mind-body therapies can be delivered.
This study demonstrated the feasibility, acceptability, and potential efficacy of a telehealth-based tai chi intervention for reducing
AI-induced arthralgia. The intervention decreased patient-reported pain and stiffness, and improved sleep quality and depressive
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symptoms. Fully powered, large, telehealth-based tai chi trials for AI-associated arthralgia are needed considering our promising
findings.
Trial Registration: ClinicalTrials.gov NCT04716920; https://www.clinicaltrials.gov/ct2/show/NCT04716920
(JMIR Form Res 2022;6(6):e34995) doi: 10.2196/34995
KEYWORDS
breast cancer; arthralgia; tai chi; telehealth, pain; mind-body therapy

Introduction
Breast cancer (BC) is the most common cancer among women
in the United States, and hormone receptor–positive BC accounts
for approximately two-thirds of all BC. For postmenopausal
women with hormone receptor–positive BC [1], long-term use
of an aromatase inhibitor (AI) for 5 to 10 years after primary
surgical treatment has been demonstrated to prevent disease
relapse and improve disease-free survival [2-4]. A meta-analysis
revealed that the overall pooled prevalence rate of AI-induced
arthralgia was 45.9% in postmenopausal hormone
receptor–positive patients with BC [5]. AI-related arthralgia
includes the new onset of worsening joint pain, stiffness, and
impaired function. Arthralgia can affect any joints but primarily
affects the hips, knees, and wrists/hands, with 70% of women
describing their joint pain as moderate to severe [6]. Symptom
onset is generally within 6 weeks to 12 months after AI initiation
but can occur even longer, and symptoms may appear abruptly
or increase gradually over time [6-8]. The clinical significance
of AI-related arthralgia is that in addition to negatively affecting
the quality of life [9] and daily activities [10], it can also
decrease patients’ adherence to AI use. Arthralgia can lead up
to 25% of patients with BC who stop AIs early and 50% of
patients who have disruptions to their treatment regimen and
schedule [6,10]. This data has important clinical implications,
as nonadherence to AIs in early BC has been shown to
negatively impact BC-related survival [10]. Other common
symptoms during AI therapy include fatigue [11], hot flashes
[12], insomnia [13], and depression [14,15], all of which can
also adversely affect a patient’s quality of life and AI treatment
adherence [15].
The approach to managing AI-related arthralgia is complex due
to the absence of validated treatment standards for clinicians to
use. They are complicated by limited knowledge regarding the
physiological
mechanisms
involved.
Unfortunately,
pharmacological interventions to treat AI-related arthralgia have
resulted in limited relief [16] and can produce undesirable side
effects and physiologic dependence, especially in elderly
patients. Lifestyle changes and complementary and alternative
interventions, including supplementation, physical activities,
and acupuncture, have been evaluated in a small number of
studies with mixed results [16]. Thus, there is a growing interest
in developing and assessing novel integrative programs to
manage this adverse event and improve patient adherence to AI
therapy.
Tai chi is a multidimensional mind-body therapy that integrates
moderate physical activity, deep breathing, and meditation;
additionally, it offers a promising approach to symptom
management in cancer populations [17]. Tai chi has been
https://formative.jmir.org/2022/6/e34995
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practiced for centuries, and approximately 25% of the urban
female population in the United States older than 50 years has
practiced tai chi [18]. Tai chi forms consist of a series of upperand lower-extremity movements performed in a particular
choreographic manner. The interplay modes may provide a
possible rationale for soft and connective tissues [17]. These
movements may induce local biochemical changes that modulate
blood circulation, improve muscle flexibility, intensify the action
of the lymphatic system, and loosen adherent connective tissue.
The loosening of the adherent connective tissue is thought to
enhance the reuptake of local nociceptive and inflammatory
mediators [17]. Randomized clinical trials (RCTs) have
demonstrated the feasibility and efficacy of tai chi for women
with BC. Studies have reported tai chi’s beneficial effects on
psychological status (eg, depression or self-efficacy), physical
function (eg, upper limb functional mobility), and other
symptoms (eg, fatigue or sleep dysfunction) [19].
Furthermore, tai chi interventions designed specifically for
individuals with pain-related conditions (eg, osteoarthritic knee
pain) have significantly improved pain and physical functional
outcomes [20]. However, there is lack of data regarding the use
of tai chi interventions to target Al-induced arthralgia for
patients with BC. Almost no tai chi interventions exist using a
remote telehealth administration for any contexts. Telehealth
or telemedicine uses telecommunications technologies for
increased access to health care. Several advantages exist for
telehealth, including the cost- and time-effectiveness, especially
amid the current COVID-19 pandemic [21,22], as cancer
survivors are at a higher risk of developing complications from
COVID-19 [23,24]. Their risk of contracting COVID-19 must
be reduced. New information and communication technology
(eg, Zoom and WhatsApp) offers a convenient solution. Aligned
with the social distancing and quarantine requirements, between
December 2020 to July 2021, we conducted a pilot study that
evaluated the feasibility, acceptability, and preliminary efficacy
of a 12-week tai chi intervention (TaiChi4Joint). The study was
aimed to reduce AI-induced arthralgia in women with BC,
delivered remotely over the Zoom videoconferencing platform
(Zoom Video Communications) facilitated by social media and
SMS text messaging–enabled engagement strategies.

Methods
Study Eligibility and Study Procedures
Inclusion criteria for study participation included participants
being ≥18 years of age, being able to speak/read English, having
been diagnosed with stage 0-III BC, being postmenopausal (ie,
no menses for at least 1 year), receiving an AI (anastrozole,
letrozole, or exemestane) for at least 2 months, having joint
JMIR Form Res 2022 | vol. 6 | iss. 6 | e34995 | p. 2
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pain that started or worsened after the initiation of AIs, reporting
that their worst pain score in the prior week was ≥4 score on a
0 to 10 scale, and willing to adhere to all the study procedures.
Exclusion criteria included having another type of cancer that
was diagnosed in the past 5 years; having uncontrolled cardiac,
pulmonary, or infectious disease; having a BMI>40 kg/m2;
currently attending any mind-body therapy classes (eg, tai chi
or yoga); having joint pain due to an inflammatory arthritic
condition; having surgery in the past 6 months; having a joint
injection in the past 3 months; currently taking corticosteroids
or opioids; or having discontinued or planning to discontinue
their AI in the next 6 months.
A research team member screened potentially eligible patients
via the electronic medical record or were referred by the
patient’s treating medical oncologists. The study team connected
with major support groups in the greater Philadelphia area to
promote the study and potentially reach eligible participants.
An informed consent form was signed, mailed, and returned by
a study participant after reviewing the study rationale,
intervention, and potential adverse effects with a research team
member. The research team also provided remote assistance
over the phone to ensure that the Zoom platform was
successfully installed on the participant’s computer, tablet, or
smartphone and that they could access classes on time.
Participants were instructed to complete baseline, 1-month,
2-month, and 3-month surveys either by a mailed paper-based
survey or via a REDCap online survey.

Ethical Approval
This study with IRB control number 20G.093 was
administratively approved by Thomas Jefferson University
Institutional Review Board on January 30, 2020 by Board
number 2405. Study accrual began in December 2020 and was
completed in April 2021.

TaiChi4Joint Study Intervention
Tai chi is a multicomponent practice that integrates physical,
psychosocial, emotional, spiritual, and behavioral elements.
Participants were invited to attend three tai chi classes per week
for the 12-week study duration via the Zoom platform. Using
a manualized approach, each class provided objectives and
learning activities. The learning activities included sequentially
learning a specific set of tai chi that included 24 movements
with verification of skills attainment on a weekly basis. Each
class began with relaxation exercises that had breathing
exercises and qigong warm-ups. The instructor reviewed the
previously learned techniques and introduced new movements
following the relaxation session. The first 8 weeks of classes
focused on mastery of single forms through multiple repetitions.
The latter weeks emphasized consolidation of daily practice
routines with natural breathing integrated into all classes.
Scheduled classes ran from 45 to 60 minutes each and occurred
4 times per week, thus allowing patients to choose 3 classes
that best fit their schedule. Participants were also encouraged
to practice these tai chi classes through video recordings and
spend 30 minutes daily on most days of the week self-practicing
the technique they learned.

https://formative.jmir.org/2022/6/e34995
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Facebook and Text Messaging–Enabled Engagement
Strategies
Participants were encouraged to join an optional Facebook
private TaiChi4joint group that consists of instructional videos
matching the progress of weekly classes for at-home practice
and promotes peer support in tai chi engagement. We used the
Facebook page and a Box shared cloud drive to share the
instructional video and the recorded live tai chi sessions for
participants who could not attend class or wanted additional
practice. Weekly Facebook posts also contained evidence-based
information about tai chi, the potential impact of tai chi in
reducing pain, class reminders, and milestone celebrations (eg,
birthday or program completion) to foster participant
engagement and community building. Further, weekly text
messages addressing class schedule, self-practice reminders,
and brief positive quotes were proactively sent to participants
to promote engagement and offer additional support.

Outcome Measures
Patient Demographics and Treatment Information
We collected the following study subject demographics and
BC-specific information: age, race, ethnicity, education, marital
status, BC diagnosis and stage, treatment history, and AI
medication type.

Feasibility
We aimed to retain 50% of eligible patients at the 3-month
follow-up survey. The cutoff of 50% retention rate was chosen
and derived from other similar pilot studies using mind-body
therapies to mitigate arthralgia [24]. Feasibility was also
measured by the participant’s class attendance, which the
research team coordinator logged each session.

Acceptability
The acceptability of the study intervention was defined as a
60% consenting rate. Justification for a 60% consenting rate as
acceptable was based on prior BC survivorship behavioral
studies [25,26]. We also asked whether participants found the
intervention helpful in reducing their pain.

Musculoskeletal Symptoms
As arthralgia primarily affects the hips and knees [6], we chose
the Western Ontario and McMaster University Osteoarthritis
Index (WOMAC) as the primary efficacy outcome. WOMAC
measures lower-extremity joint symptoms (hips/knees) in the
past 7 days in three domains: pain, stiffness, and physical
function [27]. WOMAC has been recommended with great
sensitivity for measuring changes in musculoskeletal symptoms
in patients with BC receiving AIs [28].

Hand Pain and Physical Function
We used the Australian Canadian Osteoarthritis Hand Index
(AUSCAN) to assess pain and physical function in the hands.
AUSCAN has been reported to have excellent sensitivity and
responsiveness in detecting and measuring AI-induced arthralgia
[28].
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Overall Pain

Analysis

The Brief Pain Inventory (BPI) is a 14-item questionnaire
developed for use in patients with cancer that assesses the worst
pain, pain severity, and pain interference over the past week
reported on a scale of 0 to 10. The BPI is the most common,
valid, and reliable measure to assess pain in patients with cancer.

The statistical analysis was performed using R (R Foundation
for Statistical Computing). Summary demographic statistics
were calculated. Summary statistics of the end points, WOMAC
subscales, AUSCAN subscales, BPI, FSI, HFRDIS, PSQI, and
CES-D at baseline and at 1-month, 2-month, and 3-month
follow-ups were calculated. Paired t tests of 3 months versus
baseline were performed for each end point, and findings with
95% CIs are presented. For our primary end points of the
WOMAC subscales, clinically meaningful changes in the
subscales were evaluated using the criteria >1.5 out of 20
decrease for WOMAC pain, >0.6 out of 8 decrease for WOMAC
stiffness, and >4.6 out of 68 decrease for WOMAC function
score [32]. In addition, the linear time trends of end points were
explored using latent class mixed-effect models with the R
package lcmm. Up to 3 latent classes were considered, and the
best number of latent classes was determined by the Bayesian
information criterion.

Fatigue
The Fatigue Symptom Inventory (FSI) measure is a 13-item
self-report measure shown to be sensitive to assessing change
in fatigue among patients with BC and with substantial internal
consistency. An overall score was used.

Hot Flash
We used the Hot Flash Related Daily Interference Scale
(HFRDIS) to measure the effect of hot flashes on the overall
quality of life and nine specific activities: work, social activities,
leisure activities, sleep, mood, concentration, relations with
others, sexuality, and enjoyment of life [29].

Sleep Quality
We used the Pittsburgh Sleep Quality Index (PSQI) for a
subjective sleep assessment, including multiple sleep-related
variables over the preceding month [30].

Depressive Symptoms
We used the Center for Epidemiological Studies–Depression
(CES-D) to assess depressive symptoms [31], and it has shown
excellent internal consistency and validity in patients with cancer
[32].
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Results
Patient Characteristics
The mean age of patients was 58 (SD 10.6) years. Of the 39
patients, 30 were Caucasian and 36 were at least college
graduates. There were 31 patients with stage I or II, and had
undergone mastectomy (n=22), radiation (n=27), or
chemotherapy (n=23). Half of the participants (n=21) had been
taking anastrozole. A total of 24 patients had been taking an AI
for less than 3 years (Table 1).
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Table 1. Participant characteristics.
Variable

Participants (N=39)

Age (years), mean (SD)

58.18 (10.60)

Race, n (%)
Caucasian

30 (77)

African American

7 (18)

Asian

1 (3)

Unreported

1 (3)

Ethnicity, n (%)
Non-Hispanic

38 (97)

Hispanic

1 (3)

Marital status, n (%)
Married

26 (67)

Single

7 (18)

Divorced

5 (13)

Widowed

1 (3)

Education level, n (%)
High school

3 (8)

College graduate

16 (41)

Postgraduate school

20 (51)

Breast cancer stage, n (%)
0

2 (5)

I

14 (36)

II

17 (44)

III

6 (15)

Surgerya, n (%)
Mastectomy

22 (56)

Lumpectomy

15 (39)

Radiationa, n (%)

27 (69)

Chemotherapya, n (%)

23 (59)

AIb type, n (%)
Letrozole

6 (15)

Anastrozole

21 (54)

Exemestane

9 (23)

Other

3 (8)

AI medication duration (years), n (%)

a

≤1

12 (31)

1-3

12 (31)

3-6

12 (31)

Unreported

3 (8)

Treatment options do not add up to 39 due to individual treatment choices.

b

AI: aromatase inhibitor.
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Acceptability
A total of 55 eligible patients were invited to participate, and
39 of the 55 (70.9%, 95% exact CI 57.1%-82.4%) patients
consented to study participation and completed the baseline
assessment, which exceeded the acceptability threshold of 60%.
To seek participants’ feedback on the intervention, 14 of 22
participants who completed the final survey responded to our
postintervention evaluation. All 14 perceived high satisfaction
with the intervention, and 10 reported that the intervention was
beneficial in relieving their pain.

Feasibility
Of the 39 participants, 26 completed a 1-month follow-up, 21
completed a 2-month follow-up, and 22 completed the final
3-month follow-up, with a retention rate of 56% (95% exact CI
39.6%-72.2%) at the end of the study. Study attendance was
calculated as the number of classes of the 36 suggested classes
(12 weeks × 3 per week) each participant attended, ranging from
3% (2 classes) to 100% (36 classes), with a median value of
61% (22 classes). Of the 39 participants, 16 attended 18 (50%)
or more classes during the 12-week study period.
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Change in Patient-Reported Outcomes During the
Study Duration
Table 2 shows statistically significant improvement in all our
study measures from baseline to the 3-month follow-up. Overall
pain (BPI) was reduced from 5.04 to 2.69 (P<.001). Significant
reductions also occurred in the pain subscale (from 6.64 to 3.52;
P=.007) and function subscale (from 11.13 to 5.71; P=.004) of
AUSCAN. Significant improvements were detected in fatigue
(FSI from 53.40 to 29.74; P=.004), hot flashes (HFRDIS from
28.14 to 12.44; P=.02), sleep quality (PSQI from 18 to 11.1;
P<.001), and depressive symptom (CES-D from 38.33 to 33.95;
P=.03). In particular, the significant reductions in pain (from
8.05 to 5.05; P<.001), stiffness (from 4.36 to 2.33; P<.001),
and function (from 23.28 to 11.67; P<.001) measured by
WOMAC, detected using paired t tests, were clinically
meaningful. The three P values for the WOMAC measurements
were adjusted for multiple comparison using the
Benjamini-Hochberg correction [33]. We also provide the linear
time trends estimated using latent class mixed-effect models,
with the three WOMAC measurements adjusted for multiple
comparison, as referenced in Table 2.
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Table 2. Change in patient-reported outcomes over time.
Measure (range)

a

Baseline
1 month
(N=39), mean (n=25), mean
(SD)
(SD)

2 months
(n=22), mean
(SD)

3 months
(n=21), mean
(SD)

3-month
change (95%

P value

Linear time
P value
trend detected
by the latent
class model

CI)a

WOMACb pain (0-20 8.05 (4.19)
maximal pain)

6.52 (3.70)

6.36 (4.82)

5.05 (3.89)

2.57 (1.273.87)

<.001c

–0.51

<.001c

WOMAC stiffness (0- 4.36 (1.74)
8 maximal stiffness)

3.44 (1.61)

3.00 (1.75)

2.33 (1.65)

1.67 (0.812.52)

<.001c

–0.77

<.001c

WOMAC function (0- 23.28 (14.21)
68 minimal function)

17.76 (12.36)

16.32 (13.81)

11.67 (12.70)

8.95 (5.6512.25)

<.001c

–0.71

<.001c

BPId (0-10 worse
pain)

5.04 (2.17)

4.22 (2.29)

4.16 (1.82)

2.69 (2.18)

2.25 (1.273.24)

<.001

–0.456

<.001

AUSCANe pain (0-50 6.64 (4.57)
worse pain)

6.00 (4.27)

4.77 (4.08)

3.52 (3.56)

2.33 (0.713.96)

.007

–0.642

<.001

AUSCAN function
(0-90 minimal function)

8.80 (8.10)

7.45 (7.97)

5.71 (7.27)

4.48 (1.627.33)

.004

–0.794

<.001

FSIf (0-130 worse fa- 53.40 (27.29)
tigue)

40.04 (26.53)

36.94 (22.02)

29.74 (20.05)

17.53 (6.2028.86)

.004

–0.61

<.001

HFRDISg (0-100
worse hot flash)

28.14 (25.46)

19.27 (22.89)

13.10 (14.25)

12.44 (13.78)

10.15 (2.0418.26)

.02

For 28 patients: –0.176;
for 11 patients: –1.235

For 28 patients: .14;
for 11 patients:
<.001

PSQIh (0-21 lower
sleep quality)

18.00 (5.86)

15.04 (6.52)

14.55 (5.70)

11.10 (6.40)

6.14 (3.328.96)

<.001

–0.626

<.001

CES-Di (0-60 greater
depressive symptom
severity)

38.33 (5.61)

37.40 (4.53)

36.05 (4.46)

33.95 (4.97)

2.62 (0.264.97)

.03

–0.353

<.001

11.13 (7.63)

Paired t test.

b

WOMAC: Western Ontario and McMaster University Osteoarthritis Index.

c

Adjusted for multiple comparison.

d

BPI: Brief Pain Inventory.

e

AUSCAN: Australian Canadian Osteoarthritis Hand Index.

f

FSI: Fatigue Symptom Inventory.

g

HFRDIS: Hot Flash Related Daily Interference Scale.

h

PSQI: Pittsburgh Sleep Quality Index.

i

CES-D: Center for Epidemiological Studies-Depression.

Participant Feedback and Lessons Learned
Comments and suggestions from participants, the tai chi
instructor, and our research team’s observation notes were
qualitatively summarized and discussed to reach a consensus
on each identified theme and areas for future intervention
improvement.

Improved Pain and Stiffness
Participants reported that their pain or stiffness improved, with
the change starting quickly after the first few weeks of the
intervention. The reduction in pain also facilitated other
improvements in daily activities.
Stiffness and pain decreased. I felt joints in knees and
elbows move into my sockets at some point. I’m more
https://formative.jmir.org/2022/6/e34995
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limber and able to lift my knees higher to run faster
and further.
Within 2 weeks, I had relief from the joint pain,
especially my shoulder pain.

Better Relaxation and Balance
Breathing training and exercise were recognized as helpful in
improving relaxation and calmness. Many participants also
reported their balance was improved over time.
I particularly liked the breathing exercise at the
beginning. I will continue to use it for relaxation and
mindfulness.
My flexibility and balance have improved.
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Value in Instructor Support and Facebook Group/Text
Messaging Motivation
Our tai chi instructor was perceived as highly supportive and
patient. A bonding relationship between the instructor and
participants was observed. Archived class videos and
motivational words and encouragements delivered in the
Facebook private group and SMS text messaging were also
reported as positive and helpful, motivating participant’s tai chi
practice.
The instructor was amazing and showed extraordinary
patience.
It was helpful to have all the classes on the FB page.
I enjoyed the occasional random words of kindness.

The Convenience of Virtual Classes
Participants commented on the ease and comfort of virtually
attending our tai chi classes, overcoming in-person participation
barriers such as travel burdens and demanding schedules.
The Zoom class made it easier to fit into my schedule.
I didn’t have to deal with parking.

The Limited Class Schedule
The main reason for not being able to attend scheduled classes
was the participant’s conflicting schedules. Participants reported
that their nonattendance generally reflected competing life
demands rather than their lack of desire to attend classes. Due
to the budget constraint of the pilot, the availability of our
weekly offered courses was limited with a fixed schedule of
four classes per week.
Would like to have more time options during the week
for live classes.
Unfortunately, I have only been able to attend classes
twice per week, and several times my schedule
prevented me from one of them.

Challenges of Varying Skill Levels in the Same Class
For the pilot, we used rolling enrollment, so participants started
the course as they enrolled. However, participants and the
instructor observed and reported issues of participants with
different levels of tai chi learning progression, reducing the
efficiency of the class conduct.
There were beginners starting regularly, so the pace
had to remain slow; it was difficult for me to move
very slowly when I knew the next move.

The Initial Technological Difficulty, Bandwidth
Limitation, and Online Streaming Challenges
We observed a learning curve for using the Zoom technology
when participants initially started the intervention. Some of our
older participants who joined our Zoom classes using their
cellphones experienced viewing difficulties due to the small
screen, their vision limitations, and interrupted internet signal.
The problem of following the instructor’s side-to-side
movements virtually was noted.
Having the class on Zoom presented some challenges
initially.
https://formative.jmir.org/2022/6/e34995
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It would have been helpful to have a third camera; it
was difficult keeping perspectives –rights and lefts.

Discussion
A Telehealth-Delivered Tai Chi Intervention Is Feasible
and Acceptable
AI-induced arthralgia can prohibit normal functioning and
decrease affected patients’ quality of life. Clinical trial data
show a 22% rate of AI discontinuation due to AI-induced
arthralgia [12]. Real-world data suggest that the rate of
AI-related arthralgia is as high as 50% [5], with minimal
nonpharmacological options. Our findings support the
feasibility, acceptability, and potential benefits of our
TaiChi4Joint intervention and provide direction for future
research. Due to COVID-19 social distancing constraints, our
entire study implementation procedures were remotely
conducted from the end of 2021 into early 2022. Concerning
acceptability, 28 of the 39 eligible patients agreed to participate
in our tai chi intervention delivered by Zoom. Many commented
that the main reason they were attracted to joining was the
convenience of modality, allowing them to attend classes from
home during COVID-19. With regard to feasibility, 22 of the
39 participants who completed the baseline assessment
completed the final assessment, and no safety issues were
reported. The documented 61% average class attendance rate
is not ideal, with less than 50% of participants attending half
of the suggested class dosage. Many participants reported their
nonattendance was generally due to competing work and family
demands, conflicting with the schedule of the classes offered,
as observed in the qualitative feedback. Offering a more flexible
class schedule with different skill levels in future trials could
also help to boost attendance rates by allowing participants to
choose classes at a time more convenient for them.

Tai Chi Is Effective in Relieving AI-Induced Symptoms
We also found statistically significant improvements in pain,
stiffness, impaired function, fatigue, hot flash, sleep quality,
and depressive symptoms. In particular, the change of the
WOMAC subscale scores over time, our primary outcome of
interest, was clinically meaningful based on prior literature.
Qualitative findings, including participants’ perceived reduction
in pain and stiffness, improvement in relaxation and balance,
and the value of the instructor’s and the intervention’s support,
could potentially have facilitated the quantitative change in
outcomes observed in the study. Further, to counter potential
digital divide challenges and improve participant engagement,
the following strategies addressing our lessons learned might
be helpful for future studies: include a user manual and training
session practicing joining the videoconference, offer loaner
iPads with cellular plans, use a multi-camera streaming setup,
use closed session groups, and offer a more flexible class
schedule. Our results demonstrate the potential of the
TaiChi4Joint telehealth approach and support a fully powered
RCT of TaiChi4Joint in the future.

Limitations
This is a single-arm pilot study; this design was the most suitable
to tackle the question of feasibility and acceptability. Study
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outcomes will need more scrutiny under an RCT design with a
control group. This will be required to correct for possible
selection bias or placebo effects. Selection bias might have been
a cause for the study’s favorable results, as patients adhering to
the investigation have obtained benefits derived from tai chi
practice.
A longer intervention duration and a more extended period of
follow-up post intervention might be needed to understand the
long-term and maintenance effects of tai chi in reducing
AI-induced arthralgia.
The majority of our sample were Caucasian and had a college
degree, limiting the generalization of our findings. Innovative
recruitment strategies will be needed in the future to ensure the
sample is generalizable and to increase outreach and support to
minorities.

Gomaa et al

Conclusion
COVID-19 increased stress levels while reducing access to
mind-body services in patients with cancer. Research on remote
delivery of integrative, complementary, and alternative medicine
health supports the feasibility and benefits of these services
[22,34]. Our study used existing technologies to bring tai chi
to patients’ homes. We found that tai chi reduced joint pain and
stiffness; decreased fatigue; improved sleep quality, hot flash,
and depressive symptoms; and improved functioning. Tai chi
was well tolerated, and no adverse events specific to the study
intervention occurred. Our lessons learned and strategies
described could help inform the design of telehealth-based
behavioral support. Future randomized controlled trials are
needed to establish the comparative efficacy of the TaiChi4Joint
intervention to improve outcomes related to AI-induced
arthralgia.
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